CA-PROSIMO
30.11.2022 15:02:07 CET | Business Wire | Press release
Prosimo, the Application Experience Infrastructure company, announced that it is joining forces with Amazon Web Services (AWS) to provide complete end-to-end orchestration for the new AWS Verified Access service.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221130005237/en/
Prosimo is joining forces with Amazon Web Services (AWS) to provide complete end-to-end orchestration for the new AWS Verified Access service (Graphic: Business Wire)
Prosimo is working with AWS to allow enterprises to customize and deploy zero trust network access (ZTNA) rapidly while ensuring complete data and traffic control. Prosimo's platform simplifies the orchestration of the AWS Verified Access service and provides additional performance optimization using AWS backbone, intelligent routing, and application services. Enterprises can instantaneously access any of the latest cloud-native capabilities, like AWS Verified Access, without having to re-architect their existing clouds or worry about managing multiple environments. This approach enables enterprises to quickly develop, test and deploy secure, high-performing applications across any public or hybrid cloud environment.
"Cloud-forward organizations require a cloud-native ZTNA architecture - one that combines secure access with performance and posture to meet the challenges of modern applications in the cloud," said Ramesh Prabagaran, Co-founder and CEO of Prosimo. "Our deepening work with AWS allows us to deliver tightly coupled integrations rapidly that enable customers to simplify and streamline IT operations with fewer resources."
Why traditional ZTNA solutions fall short
Traditional ZTNA approaches take traffic to the vendor cloud-first to enforce policies and bring it back to the AWS Region close to the application. The model breaks a well-architected framework by not utilizing cloud-native services and optimized flows using AWS backbone and services such as AWS Transit Gateway, AWS Cloud WAN, AWS Global Accelerator, and AWS PrivateLink. This often leads to operational complexity, increasing risk, escalating costs, and negative impacts on performance.
Secure Access + Performance at Cloud Speed
Prosimo provides an end-to-end orchestration solution with advanced controls using these cloud-native services from AWS. The Prosimo Full Stack takes a comprehensive approach to help customers deploy AWS Verified Access and includes performance optimization, secure access, dynamic risk calculation, and orchestration of all ecosystem components, such as identity provider [IDP] integration, Domain Name Service [DNS], and connectivity, without any traffic leaving customers’ AWS environment. In addition to secure access, Prosimo can balance and optimize performance and costs per application basis.
One-click purchase and billing in AWS Marketplace
Prosimo solutions are available in AWS Marketplace and allow customers to seamlessly consume Prosimo solutions with one easy click of a button and consolidate billing.
Resources
- 2022 Gartner® Market Guide for Multicloud Networking Software
- Turbo Charge ZTNA with Prosimo and AWS [Technical Blog]
- AWS + Prosimo
- Prosimo Full Stack Cloud Transit
- Prosimo + AWS Cloud WAN
- Cloud Field Day: Simplifying Multi-Cloud Networking with Prosimo
Connect with Prosimo
About Prosimo
Prosimo delivers a simplified multicloud infrastructure for distributed enterprise cloud journeys. Companies innovate faster and remain in control with the Prosimo integrated stack. This stack combines cloud networking, performance, security, observability, and cost management—all powered by data insights and machine learning models with autonomous cloud networking to reduce complexity and risk. Cloud-forward enterprises, including F100, have adopted Prosimo to successfully roll out revenue-generating applications, improve operational efficiency, and accelerate positive business outcomes. Prosimo is venture-backed by marquee investors such as General Catalyst, WRVI Capital, and Blackrock. For more information, visit https://www.prosimo.io.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005237/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4*12.11.2026 23:07:00 CET | Press release
The multi-level takeover includes a Throne Room, interactive photo opportunities, special lighting, and more The Empire State Building (ESB) is the gateway to Mount Olympus in Percy Jackson’s world, and now fans can experience the magic like never before. On Nov. 16, the Empire State Building Observation Deck (ESBOD) will unveil “Olympus Awaits,” a multi-level “Percy Jackson and the Olympians” takeover, in partnership with Disney+. The immersive takeover – included with every Observation Deck ticket – will feature an epic Throne Room, interactive photo opportunities, surprise giveaways, ESB x “Percy Jackson” merch, and more, available through Dec. 4, 2026.* This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112442266/en/ Empire State Building Observation Deck to Debut ‘Olympus Awaits,’ An Immersive ‘Percy Jackson and the Olympians’ Takeover in the Heart of NYC, On Display from Nov. 16 – Dec. 4* “This immersive NYC experience
Clene Nanomedicine Partners with Veristat to Reduce Biostatistical Output Time by 80% for ALS New Drug Application12.11.2026 18:09:00 CET | Press release
Veristat’s InStat™ delivers submission-ready tables, listings, and figures (TLFs) in one week using validated statistical engines, shortening the critical path from database lock to submission VeristatTM, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced that it has partnered with Clene Nanomedicine to cut the time to deliver biostatistical outputs for a pivotal ALS drug application submission by 80%. Veristat reduced the time from study data to validated tables, listings and figures (TLFs) from up to six weeks to just one week. Clene, a late-stage biotech company, leveraged Veristat’s recently launched InStat™ platform, the industry’s first zero-code, fully automated solution to accelerate clinical trial processes. Biostatistical TLFs sit on the critical path for submissions, yet most sponsors rely on antiquated processes that involve slow, manual workflows to produce them, making post-database lock one of the biggest bottlenecks
WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network12.11.2026 18:00:00 CET | Press release
New feature lets members follow friends and family, share performance and health insights, and celebrate life's moments together WHOOP, the human performance brand, today launched WHOOP Humans, a new feature that lets members follow friends and family, share fitness, health, and performance data they choose, and support each other's progress. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112176779/en/ WHOOP Launches WHOOP Humans, the Most Verifiably Human Social Network For more than a decade, WHOOP has helped members better understand their own health and performance. Now, WHOOP Humans extends that experience beyond the individual, making it easier to celebrate achievements, encourage progress, and look out for the people who matter most. "In a world that's becoming increasingly artificial, we're building something deeply human,” said Will Ahmed, Founder and CEO of WHOOP. “This is the most verifiably human network ever
Integrated Hubs for Green Chemistry Research Aim to Transform How Chemicals and Materials Are Designed12.11.2026 17:00:00 CET | Press release
International network will investigate fundamental principles for creating safer, higher-performing chemicals and materials The Gordon and Betty Moore Foundation today announced four Integrated Research Hubs to explore new frontiers in chemical design, from materials that respond to their surroundings to molecules designed for safety from the start. Bringing together global researchers across institutions and disciplines, the hubs will investigate fundamental principles that could enable new capabilities in chemicals and materials while improving performance and protecting human health and the environment. The research priorities emerged through extensive engagement with the scientific community to identify the questions that could transform what chemistry can achieve. Each hub will connect researchers across institutions around one of four green chemistry focus areas: Safer molecular design: Led by The George Washington University, this hub will combine artificial intelligence and qua
Roquette Highlights Scalable Excipient and Capsule Solutions for Regional and Global Pharmaceutical Markets at CPHI India 202612.11.2026 16:00:00 CET | Press release
Helping pharmaceutical manufacturers accelerate the journey from formulation to market through deep technical expertise, meaningful innovation, close collaboration and global capabilities Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical excipients, will showcase its comprehensive portfolio of excipient and capsule solutions at CPHI India 2026, Hall 1, Booth 1I12 from November 23 to 25, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112803410/en/ Meet Roquette at CPHI India 2026, Hall 1, Booth 1I12 At the event, Roquette will demonstrate how it helps pharmaceutical manufacturers accelerate the journey from formulation to market with confidence. By combining technical expertise, trusted quality, meaningful innovation and close collaboration, Roquette helps customers address formulation, scale-up and manufacturing challenges across a broad range of pharmaceutical application
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom